\-\ Texto\\:\\ \ \(0\)\
\-\ hyperechoic\\ renal\\ pyramids\\ with\\ faint\\ shadowing\\.\ \(0\)\
\-\ medullary\\ nephrocalcinosis\\ likely\\ secondary\\ to\\ wilson\\'s\\ syndrome\ \(0\)\
\-\ pathognomonic\\.\ \(5\)\
\-\ causes\\ include\\:\ \(1\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ renal\\ tubular\\ acidosis\ \(5\)\
\-\ medullary\\ sponge\\ kidney\ \(4\)\
\-\ papillary\\ necrosis\ \(4\)\
\-\ other\\:\\ drugs\\ \\(furosemide\\,amphotericin\\,steroids\\,etc\\)\\,\\ chronic\\ pyelonephritis\ \(0\)\
\-\ wilson\\'s\\ syndrome\ \(0\)\
\-\ a\\ patient\\ with\\ wilson\\'s\\ syndrome\\ presents\\ with\\ a\\ urinary\\ tract\\ infection\\.\ \(0\)\
\-\ wilson\\'s\\ disease\\ can\\ be\\ a\\ cause\\ of\\ medullary\\ nephrocalcinosis\\.\\ \\ the\\ patient\\ in\\ this\\ case\\ did\\ not\\ have\\ other\\ associated\\ risk\\ factors\\ for\\ nephrocalcinosis\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ wilson\\:\\ 0\\.26938710449920855\ \(0\)\
\-\ nephrocalcinosis\\:\\ 0\\.21114017929095114\ \(0\)\
\-\ medullary\\:\\ 0\\.14491723138779403\ \(0\)\
\-\ \\'s\\:\\ 0\\.08866101733491977\ \(0\)\
\-\ syndrome\\:\\ 0\\.08625552623769323\ \(0\)\
\-\ furosemide\\:\\ 0\\.07924796332101955\ \(0\)\
\-\ amphotericin\\:\\ 0\\.07447778557857056\ \(0\)\
\-\ pyramids\\:\\ 0\\.07266424816883811\ \(0\)\
\-\ sponge\\:\\ 0\\.07038005976365037\ \(0\)\
\-\ acidosis\\:\\ 0\\.06493743009367257\ \(0\)\
\-\ faint\\:\\ 0\\.06369789461534521\ \(0\)\
\-\ renal\\:\\ 0\\.060411189399013396\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.05866914149973416\ \(0\)\
\-\ drugs\\:\\ 0\\.05554322190287527\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.0544219256698832\ \(0\)\
\-\ etc\\:\\ 0\\.0544219256698832\ \(0\)\
\-\ shadowing\\:\\ 0\\.05339826241118168\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.05276217745506079\ \(0\)\
\-\ papillary\\:\\ 0\\.05103743069986225\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.050261454608194055\ \(0\)\
\-\ steroids\\:\\ 0\\.04729091621611479\ \(0\)\
\-\ tubular\\:\\ 0\\.046814547259000236\ \(0\)\
\-\ urinary\\:\\ 0\\.04653771787770383\ \(0\)\
\-\ other\\:\\ 0\\.04634443644005761\ \(0\)\
\-\ factors\\:\\ 0\\.04516217272406969\ \(0\)\
\-\ tract\\:\\ 0\\.0445303588538125\ \(0\)\
\-\ necrosis\\:\\ 0\\.03968353780523182\ \(0\)\
\-\ causes\\:\\ 0\\.03913624350364484\ \(0\)\
\-\ risk\\:\\ 0\\.03641419585128337\ \(0\)\
\-\ did\\:\\ 0\\.03629904283521087\ \(0\)\
\-\ kidney\\:\\ 0\\.03541627594176482\ \(0\)\
\-\ cause\\:\\ 0\\.03401485443002313\ \(0\)\
\-\ infection\\:\\ 0\\.029223724400856552\ \(0\)\
\-\ likely\\:\\ 0\\.02835635254041949\ \(0\)\
\-\ chronic\\:\\ 0\\.02831752509302353\ \(0\)\
\-\ include\\:\\ 0\\.028201805741532783\ \(0\)\
\-\ secondary\\:\\ 0\\.028106234900103617\ \(0\)\
\-\ \\:\\:\\ 0\\.02659470155272153\ \(0\)\
\-\ associated\\:\\ 0\\.02372308896362002\ \(0\)\
\-\ can\\:\\ 0\\.022802615911400818\ \(0\)\
\-\ case\\:\\ 0\\.02199416979843848\ \(0\)\
\-\ have\\:\\ 0\\.021769859745471666\ \(0\)\
\-\ presents\\:\\ 0\\.020536991711857952\ \(0\)\
\-\ patient\\:\\ 0\\.020155104256856186\ \(0\)\
\-\ disease\\:\\ 0\\.016432206367243577\ \(0\)\
\-\ be\\:\\ 0\\.01550302027463446\ \(0\)\
\-\ not\\:\\ 0\\.014527278491081593\ \(0\)\
\-\ a\\:\\ 0\\.013997640064185928\ \(0\)\
\-\ \\,\\:\\ 0\\.012739297200813524\ \(0\)\
\-\ this\\:\\ 0\\.011307496627225095\ \(0\)\
\-\ for\\:\\ 0\\.008577742925208413\ \(0\)\
\-\ \\(\\:\\ 0\\.008498373249927771\ \(0\)\
\-\ \\)\\:\\ 0\\.008394561083685942\ \(0\)\
\-\ to\\:\\ 0\\.005024330687564544\ \(0\)\
\-\ in\\:\\ 0\\.0049576144722382936\ \(0\)\
\-\ with\\:\\ 0\\.004129559156113755\ \(0\)\
\-\ \\.\\:\\ 0\\.0016705664045810011\ \(0\)\
\-\ the\\:\\ 0\\.001626462172983833\ \(0\)\
\-\ of\\:\\ 0\\.0013706329505645696\ \(0\)\
